Diabetes Drugs Market Research Reports
Title | published | price | |
---|---|---|---|
Global Repaglinide Professional Survey Report 2022, Forecast to 2027By Multimarket Insight "...... Proper control of diabetes may also lessen your risk of a heart attack or stroke. It works by stimulating the body to produce more insulin. Insulin is a natural substance that allows the body to properly use sugar from the diet.
We aims to pr......" | 08-Mar-2022 | $3280 | |
Global Incretin-Based Drugs Market Research Report 2022, Forecast to 2027By Multimarket Insight "...... de a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are r......" | 08-Mar-2022 | $2680 | |
Global Incretin-Based Drugs Professional Survey Report 2022, Forecast to 2027By Multimarket Insight "...... de a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are r......" | 08-Mar-2022 | $3280 | |
Global Repaglinide Market Research Report 2022, Forecast to 2027By Multimarket Insight "...... Proper control of diabetes may also lessen your risk of a heart attack or stroke. It works by stimulating the body to produce more insulin. Insulin is a natural substance that allows the body to properly use sugar from the diet.
We aims to pr......" | 08-Mar-2022 | $2680 | |
Global Antidiabetic SGLT-2 Inhibitor Market Research Report 2022, Forecast to 2027By Multimarket Insight "...... ere the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Antidiabetic S......" | 04-Mar-2022 | $2680 | |
Global Antidiabetic SGLT-2 Inhibitor Professional Survey Report 2022, Forecast to 2027By Multimarket Insight "...... ere the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Antidiabetic S......" | 04-Mar-2022 | $3280 | |
Global Incretin-Based Drugs Market Insights and Forecast to 2028By QYResearch Group "...... st by Type and by Application for the period 2017-2028.
Segment by Type
- Glucagon-like peptide-1 receptor (GLP-1) agonists
- Dipeptidyl Peptidase-4 (DPP-4) inhibitors
Segment by Application
- Oral D......" | 28-Feb-2022 | $4900 | |
Global Lixisenatide Market Insights and Forecast to 2028By QYResearch Group "...... y Application for the period 2017-2028.
Segment by Type
- Tablet
- Liquid Injection
Segment by Application
- Hospital
- Clinic
- Medical center
- Others
By Company......" | 28-Feb-2022 | $4900 | |
Global Antidiabetic Biguanides Market Insights and Forecast to 2028By QYResearch Group "...... forecast by Type and by Application for the period 2017-2028.
Segment by Type
- Metformin IR
- Metformin SR
Segment by Application
- Hospitals
- Clinics
- Other
By Compan......" | 28-Feb-2022 | $4900 | |
Global Antidiabetic Sulphonylureas Market Insights and Forecast to 2028By QYResearch Group "...... nue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
- First Generation Antidiabetic Sulphonylureas
- The Second Generation Antidiabetic Sulphonylureas
- The Third Generation Antidi......" | 28-Feb-2022 | $4900 | |
|